drug protocol number

LA38-0411

drug sponsor

ApoPharma Inc.

drug study

Deferiprone Deferoxamine

drug trial site

Aseer Central Hospital, King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase